{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T08:59:05Z","timestamp":1766048345443},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T00:00:00Z","timestamp":1346889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10585-012-9530-0","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T07:47:46Z","timestamp":1346831266000},"page":"225-236","source":"Crossref","is-referenced-by-count":13,"title":["A micro-imaging study linking bone cancer pain with tumor growth and bone resorption in a rat model"],"prefix":"10.1007","volume":"30","author":[{"given":"Louis","family":"Dor\u00e9-Savard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Beaudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Sarret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,6]]},"reference":[{"issue":"6","key":"9530_CR1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK (2011) Cancer to bone: a fatal attraction. Nat Rev Cancer 11(6):411\u2013425","journal-title":"Nat Rev Cancer"},{"issue":"20 Pt 2","key":"9530_CR2","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(20 Pt 2):6243s\u20136249s","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9530_CR3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","volume":"7","author":"LJ Suva","year":"2011","unstructured":"Suva LJ et al (2011) Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 7(4):208\u2013218","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"9530_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277\u2013300","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"9530_CR5","first-page":"1153","volume":"21","author":"M Trinkaus","year":"2009","unstructured":"Trinkaus M et al (2009) Examination of the mechanisms of osteolysis in patients with metastatic breast cancer. Oncol Rep 21(5):1153\u20131159","journal-title":"Oncol Rep"},{"issue":"14 Suppl 5","key":"9530_CR6","first-page":"21","volume":"23","author":"KO Rove","year":"2009","unstructured":"Rove KO, Crawford ED (2009) Metastatic cancer in solid tumors and clinical outcome: skeletal-related events. Oncology 23(14 Suppl 5):21\u201327","journal-title":"Oncology"},{"issue":"8 Suppl","key":"9530_CR7","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","volume":"80","author":"RE Coleman","year":"1997","unstructured":"Coleman RE (1997) Skeletal complications of malignancy. Cancer 80(8 Suppl):1588\u20131594","journal-title":"Cancer"},{"key":"9530_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2407-11-29","volume":"11","author":"AO Jensen","year":"2011","unstructured":"Jensen AO et al (2011) Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer 11:29","journal-title":"BMC Cancer"},{"issue":"9","key":"9530_CR9","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH Beuken-van Everdingen van den","year":"2007","unstructured":"van den Beuken-van Everdingen MH et al (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40\u00a0years. Ann Oncol 18(9):1437\u20131449","journal-title":"Ann Oncol"},{"issue":"1","key":"9530_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpainsymman.2007.12.014","volume":"37","author":"AM Kirou-Mauro","year":"2009","unstructured":"Kirou-Mauro AM et al (2009) Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. J Pain Symptom Manag 37(1):77\u201384","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"9530_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.suponc.2011.06.004","volume":"9","author":"FM Paes","year":"2011","unstructured":"Paes FM et al (2011) Radiopharmaceuticals: when and how to use them to treat metastatic bone pain. J Support Oncol 9(6):197\u2013205","journal-title":"J Support Oncol"},{"issue":"3","key":"9530_CR12","first-page":"220","volume":"58","author":"C Pacharinsak","year":"2008","unstructured":"Pacharinsak C, Beitz A (2008) Animal models of cancer pain. Comp Med 58(3):220\u2013233","journal-title":"Comp Med"},{"key":"9530_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.2009.05429.x","volume":"1198","author":"JM Jimenez-Andrade","year":"2010","unstructured":"Jimenez-Andrade JM et al (2010) Bone cancer pain. Ann N Y Acad Sci 1198:173\u2013181","journal-title":"Ann N Y Acad Sci"},{"issue":"24","key":"9530_CR14","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1523\/JNEUROSCI.19-24-10886.1999","volume":"19","author":"MJ Schwei","year":"1999","unstructured":"Schwei MJ et al (1999) Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 19(24):10886\u201310897","journal-title":"J Neurosci"},{"issue":"4","key":"9530_CR15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.bbrc.2006.04.186","volume":"345","author":"QL Mao-Ying","year":"2006","unstructured":"Mao-Ying QL et al (2006) A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem Biophys Res Commun 345(4):1292\u20131298","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"9530_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3959(01)00437-7","volume":"96","author":"SJ Medhurst","year":"2002","unstructured":"Medhurst SJ et al (2002) A rat model of bone cancer pain. Pain 96(1\u20132):129\u2013140","journal-title":"Pain"},{"issue":"1\u20132","key":"9530_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2005.08.001","volume":"118","author":"RX Zhang","year":"2005","unstructured":"Zhang RX et al (2005) Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118(1\u20132):125\u2013136","journal-title":"Pain"},{"issue":"7","key":"9530_CR18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.ajp.0000210902.67849.e6","volume":"22","author":"KG Halvorson","year":"2006","unstructured":"Halvorson KG et al (2006) Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. Clin J Pain 22(7):587\u2013600","journal-title":"Clin J Pain"},{"issue":"6","key":"9530_CR19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jpain.2010.12.016","volume":"12","author":"AP Bloom","year":"2011","unstructured":"Bloom AP et al (2011) Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers. J Pain 12(6):698\u2013711","journal-title":"J Pain"},{"issue":"44","key":"9530_CR20","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1523\/JNEUROSCI.3300-10.2010","volume":"30","author":"JM Jimenez-Andrade","year":"2010","unstructured":"Jimenez-Andrade JM et al (2010) Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J Neurosci 30(44):14649\u201314656","journal-title":"J Neurosci"},{"issue":"11","key":"9530_CR21","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.pain.2011.07.020","volume":"152","author":"JM Jimenez-Andrade","year":"2011","unstructured":"Jimenez-Andrade JM et al (2011) Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain 152(11):2564\u20132574","journal-title":"Pain"},{"issue":"24","key":"9530_CR22","first-page":"7343","volume":"62","author":"MA Sabino","year":"2002","unstructured":"Sabino MA et al (2002) Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 62(24):7343\u20137349","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"9530_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pain.2003.09.003","volume":"107","author":"A Fox","year":"2004","unstructured":"Fox A et al (2004) Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Pain 107(1\u20132):33\u201340","journal-title":"Pain"},{"issue":"2","key":"9530_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00774-006-0734-8","volume":"25","author":"M Nagae","year":"2007","unstructured":"Nagae M, Hiraga T, Yoneda T (2007) Acidic microenvironment created by osteoclasts causes bone pain associated with tumor colonization. J Bone Miner Metab 25(2):99\u2013104","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"9530_CR25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pbb.2007.03.017","volume":"87","author":"M Mouedden El","year":"2007","unstructured":"El Mouedden M, Meert TF (2007) The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain. Pharmacol Biochem Behav 87(1):30\u201340","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"9530_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2004.06.015","volume":"111","author":"MA Sevcik","year":"2004","unstructured":"Sevcik MA et al (2004) Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis. Pain 111(1\u20132):169\u2013180","journal-title":"Pain"},{"issue":"12","key":"9530_CR27","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.clinthera.2004.12.010","volume":"26","author":"D Tripathy","year":"2004","unstructured":"Tripathy D, Body JJ, Bergstrom B (2004) Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trials. Clin Ther 26(12):1947\u20131959","journal-title":"Clin Ther"},{"key":"9530_CR28","doi-asserted-by":"crossref","unstructured":"Jimenez Andrade JM, Mantyh P (2010) Cancer pain: from the development of mouse models to human clinical trials. Translational pain research: from mouse to man. Frontiers in Neuroscience. CRC Press, Boca Raton","DOI":"10.1201\/9781439812105-c4"},{"issue":"6","key":"9530_CR29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1470-2045(09)70088-9","volume":"10","author":"CM Costelloe","year":"2009","unstructured":"Costelloe CM et al (2009) Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol 10(6):606\u2013614","journal-title":"Lancet Oncol"},{"issue":"4","key":"9530_CR30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdr397","volume":"23","author":"N Houssami","year":"2012","unstructured":"Houssami N, Costelloe CM (2012) Imaging bone metastases in breast cancer: evidence on comparative test accuracy. Ann Oncol 23(4):834\u2013843","journal-title":"Ann Oncol"},{"issue":"3","key":"9530_CR31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2967\/jnumed.107.045666","volume":"49","author":"WK Hsu","year":"2008","unstructured":"Hsu WK et al (2008) Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET\/CT. J Nucl Med 49(3):414\u2013421","journal-title":"J Nucl Med"},{"issue":"10","key":"9530_CR32","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.2967\/jnumed.110.078899","volume":"51","author":"S Zitzmann-Kolbe","year":"2010","unstructured":"Zitzmann-Kolbe S et al (2010) D-18F-fluoromethyl tyrosine imaging of bone metastases in a mouse model. J Nucl Med 51(10):1632\u20131636","journal-title":"J Nucl Med"},{"issue":"1","key":"9530_CR33","first-page":"15","volume":"14","author":"C Cheng","year":"2011","unstructured":"Cheng C et al (2011) Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG. Hell J Nucl Med 14(1):15\u201320","journal-title":"Hell J Nucl Med"},{"issue":"2","key":"9530_CR34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2010.08.019","volume":"47","author":"M Merz","year":"2011","unstructured":"Merz M et al (2011) Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases. Eur J Cancer 47(2):277\u2013286","journal-title":"Eur J Cancer"},{"issue":"12","key":"9530_CR35","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1158\/1078-0432.CCR-09-2932","volume":"16","author":"T Bauerle","year":"2010","unstructured":"Bauerle T et al (2010) Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study. Clin Cancer Res 16(12):3215\u20133225","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9530_CR36","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.ejrad.2010.10.024","volume":"81","author":"J Grankvist","year":"2012","unstructured":"Grankvist J et al (2012) MRI and PET\/CT of patients with bone metastases from breast carcinoma. Eur J Radiol 81(1):e13\u2013e18","journal-title":"Eur J Radiol"},{"issue":"1","key":"9530_CR37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2010.05.037","volume":"48","author":"L Walkington","year":"2011","unstructured":"Walkington L, Coleman RE (2011) Advances in management of bone disease in breast cancer. Bone 48(1):80\u201387","journal-title":"Bone"},{"issue":"1","key":"9530_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","volume":"49","author":"RE Coleman","year":"2011","unstructured":"Coleman RE, McCloskey EV (2011) Bisphosphonates in oncology. Bone 49(1):71\u201376","journal-title":"Bone"},{"issue":"1","key":"9530_CR39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.breast.2011.08.138","volume":"21","author":"MS Aapro","year":"2012","unstructured":"Aapro MS, Coleman RE (2012) Bone health management in patients with breast cancer: current standards and emerging strategies. Breast 21(1):8\u201319","journal-title":"Breast"},{"issue":"2","key":"9530_CR40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"10","key":"9530_CR41","doi-asserted-by":"crossref","first-page":"e13774","DOI":"10.1371\/journal.pone.0013774","volume":"5","author":"L Dor\u00e9-Savard","year":"2010","unstructured":"Dor\u00e9-Savard L et al (2010) Behavioral, medical imaging and histological features of a new rat model of bone cancer pain. PLoS One 5(10):e13774","journal-title":"PLoS One"},{"issue":"3","key":"9530_CR42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.physbeh.2011.05.015","volume":"104","author":"P Tetreault","year":"2011","unstructured":"Tetreault P et al (2011) Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats. Physiol Behav 104(3):495\u2013502","journal-title":"Physiol Behav"},{"key":"9530_CR43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2011.01.039","volume":"178","author":"G Castaneda-Corral","year":"2011","unstructured":"Castaneda-Corral G et al (2011) The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. Neuroscience 178:196\u2013207","journal-title":"Neuroscience"},{"issue":"4","key":"9530_CR44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/CCO.0b013e3281214400","volume":"19","author":"S Mercadante","year":"2007","unstructured":"Mercadante S, Fulfaro F (2007) Management of painful bone metastases. Curr Opin Oncol 19(4):308\u2013314","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"9530_CR45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","volume":"104","author":"MS Angst","year":"2006","unstructured":"Angst MS, Clark JD (2006) Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104(3):570\u2013587","journal-title":"Anesthesiology"},{"issue":"1\u20132","key":"9530_CR46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pain.2007.06.026","volume":"132","author":"T King","year":"2007","unstructured":"King T et al (2007) Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. Pain 132(1\u20132):154\u2013168","journal-title":"Pain"},{"issue":"14","key":"9530_CR47","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","volume":"22","author":"T Hamaoka","year":"2004","unstructured":"Hamaoka T et al (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22(14):2942\u20132953","journal-title":"J Clin Oncol"},{"issue":"5","key":"9530_CR48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10585-005-1264-9","volume":"22","author":"KM Gauvain","year":"2005","unstructured":"Gauvain KM et al (2005) MRI detection of early bone metastases in b16 mouse melanoma models. Clin Exp Metastasis 22(5):403\u2013411","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"9530_CR49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MNM.0b013e3282f258c1","volume":"29","author":"L Wang","year":"2008","unstructured":"Wang L et al (2008) MRI and hybrid PET\/CT for monitoring tumour metastasis in a metastatic breast cancer model in rabbit. Nucl Med Commun 29(2):137\u2013143","journal-title":"Nucl Med Commun"},{"issue":"1","key":"9530_CR50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pros.20494","volume":"67","author":"V Kundra","year":"2007","unstructured":"Kundra V et al (2007) In vivo imaging of prostate cancer involving bone in a mouse model. Prostate 67(1):50\u201360","journal-title":"Prostate"},{"issue":"3","key":"9530_CR51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2463\/mrms.7.105","volume":"7","author":"K Murakami","year":"2008","unstructured":"Murakami K et al (2008) Correlation between high field MR images and histopathological findings of rat transplanted cancer immediately after partial microwave coagulation. Magn Reson Med Sci 7(3):105\u2013112","journal-title":"Magn Reson Med Sci"},{"issue":"5","key":"9530_CR52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RLI.0b013e31819dcc84","volume":"44","author":"W Reichardt","year":"2009","unstructured":"Reichardt W et al (2009) Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma. Invest Radiol 44(5):298\u2013303","journal-title":"Invest Radiol"},{"issue":"1","key":"9530_CR53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jcb.22056","volume":"107","author":"S Rozel","year":"2009","unstructured":"Rozel S et al (2009) Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J Cell Biochem 107(1):58\u201364","journal-title":"J Cell Biochem"},{"issue":"3","key":"9530_CR54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-3959(02)00040-4","volume":"100","author":"K Walker","year":"2002","unstructured":"Walker K et al (2002) Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain 100(3):219\u2013229","journal-title":"Pain"},{"issue":"1","key":"9530_CR55","doi-asserted-by":"crossref","first-page":"e29615","DOI":"10.1371\/journal.pone.0029615","volume":"7","author":"M Shah","year":"2012","unstructured":"Shah M et al (2012) An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer. PLoS ONE 7(1):e29615","journal-title":"PLoS ONE"},{"issue":"7","key":"9530_CR56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4161\/cbt.9.7.11266","volume":"9","author":"PM Holland","year":"2010","unstructured":"Holland PM et al (2010) Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L\/TRAIL\/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis. Cancer Biol Ther 9(7):539\u2013550","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"9530_CR57","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pbb.2008.05.016","volume":"90","author":"CI Svensson","year":"2008","unstructured":"Svensson CI et al (2008) Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced pain. Pharmacol Biochem Behav 90(4):664\u2013675","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"9530_CR58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bone.2010.09.019","volume":"48","author":"JR Ghilardi","year":"2011","unstructured":"Ghilardi JR et al (2011) Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers. Bone 48(2):389\u2013398","journal-title":"Bone"},{"issue":"2","key":"9530_CR59","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuroscience.2010.08.056","volume":"171","author":"WG Mantyh","year":"2010","unstructured":"Mantyh WG et al (2010) Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience 171(2):588\u2013598","journal-title":"Neuroscience"},{"issue":"1","key":"9530_CR60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.expneurol.2004.11.028","volume":"193","author":"CM Peters","year":"2005","unstructured":"Peters CM et al (2005) Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol 193(1):85\u2013100","journal-title":"Exp Neurol"},{"issue":"1\u20132","key":"9530_CR61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pain.2005.02.022","volume":"115","author":"MA Sevcik","year":"2005","unstructured":"Sevcik MA et al (2005) Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain 115(1\u20132):128\u2013141","journal-title":"Pain"},{"issue":"9","key":"9530_CR62","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/brain\/awq194","volume":"133","author":"TK Kaan","year":"2010","unstructured":"Kaan TK et al (2010) Systemic blockade of P2X3 and P2X2\/3 receptors attenuates bone cancer pain behaviour in rats. Brain 133(9):2549\u20132564","journal-title":"Brain"},{"key":"9530_CR63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1744-8069-6-87","volume":"6","author":"JR Ghilardi","year":"2010","unstructured":"Ghilardi JR et al (2010) Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain. Mol Pain 6:87","journal-title":"Mol Pain"},{"issue":"3","key":"9530_CR64","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ijc.23157","volume":"122","author":"P Zwolak","year":"2008","unstructured":"Zwolak P et al (2008) Local irradiation in combination with bevacizumab enhances radiation control of bone destruction and cancer-induced pain in a model of bone metastases. Int J Cancer 122(3):681\u2013688","journal-title":"Int J Cancer"},{"key":"9530_CR65","first-page":"120","volume":"312","author":"JA Hipp","year":"1995","unstructured":"Hipp JA, Springfield DS, Hayes WC (1995) Predicting pathologic fracture risk in the management of metastatic bone defects. Clin Orthop Relat Res 312:120\u2013135","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"9530_CR66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pbb.2005.07.016","volume":"82","author":"M Mouedden El","year":"2005","unstructured":"El Mouedden M, Meert TF (2005) Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain. Pharmacol Biochem Behav 82(1):109\u2013119","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"9530_CR67","doi-asserted-by":"crossref","first-page":"e10234","DOI":"10.1371\/journal.pone.0010234","volume":"5","author":"Z Tong","year":"2010","unstructured":"Tong Z et al (2010) Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain. PLoS ONE 5(4):e10234","journal-title":"PLoS ONE"},{"issue":"1","key":"9530_CR68","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bone.2010.07.009","volume":"48","author":"T Yoneda","year":"2011","unstructured":"Yoneda T et al (2011) Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain. Bone 48(1):100\u2013105","journal-title":"Bone"},{"issue":"3","key":"9530_CR69","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/SPC.0b013e328349731c","volume":"5","author":"A Lipton","year":"2011","unstructured":"Lipton A, Jacobs I (2011) Denosumab: benefits of RANK ligand inhibition in cancer patients. Curr Opin Support Palliat Care 5(3):258\u2013264","journal-title":"Curr Opin Support Palliat Care"},{"issue":"3","key":"9530_CR70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/14728214.2011.588600","volume":"16","author":"F Pantano","year":"2011","unstructured":"Pantano F et al (2011) New targets, new drugs for metastatic bone pain: a new philosophy. Expert Opin Emerg Drugs 16(3):403\u2013405","journal-title":"Expert Opin Emerg Drugs"},{"issue":"3","key":"9530_CR71","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ncponc1323","volume":"6","author":"L Costa","year":"2009","unstructured":"Costa L, Major PP (2009) Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nat Clin Pract Oncol 6(3):163\u2013174","journal-title":"Nat Clin Pract Oncol"},{"issue":"Suppl 1","key":"9530_CR72","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S1040-8428(11)70006-3","volume":"77","author":"L Costa","year":"2011","unstructured":"Costa L et al (2011) Anticancer evidence for zoledronic acid across the cancer continuum. Crit Rev Oncol Hematol 77(Suppl 1):S31\u2013S37","journal-title":"Crit Rev Oncol Hematol"},{"key":"9530_CR73","unstructured":"Zheleznyak A et al. (2011) Integrin alpha(v)beta (3) as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. Mol Imaging Biol Aug 19: 1\u20139"},{"issue":"5","key":"9530_CR74","first-page":"317","volume":"14","author":"MJ Lage","year":"2008","unstructured":"Lage MJ et al (2008) The cost of treating skeletal-related events in patients with prostate cancer. Am J Manag Care 14(5):317\u2013322","journal-title":"Am J Manag Care"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-012-9530-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-012-9530-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-012-9530-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T11:43:19Z","timestamp":1562154199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-012-9530-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,6]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9530"],"URL":"https:\/\/doi.org\/10.1007\/s10585-012-9530-0","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,6]]}}}